â– PHYSIOLOGICAL CORE: Somatostatin (SST) is a key inhibitory peptide synthesized and secreted by gastric D-cells, pancreatic delta cells, and enteric neurons.
â– INHIBITORY MECHANISMS:
1. Parietal Acid Inhibition: Directly inhibits parietal cell acid product via Gi-coupled pathways, and indirectly suppresses G-cells (releasing gastrin) and ECL cells (releasing histamine).
2. Exocrine Suppression: Directly inhibits pancreatic enzyme and fluid secretion, reducing bile and pancreatic output.
3. Intestinal Motility Inhibition: Slows gastric emptying, limits intestinal transit time, and reduces splanchnic blood flow.
â– PHYSIOLOGICAL METABOLIC RECOVERY LOOPS:
Intense pathologic strain initiates systemic arterial, neural, or renal neurohormonal feedback mechanisms to maintain oxygenation, cellular pH balance, and blood pressure in critical territories.
â– GERIATRIC PHYSIOLOGIC ADJUSTMENTS:
Older patients display reduced physiological reserves, altered muscle-to-fat distributions, and distinct renal filtration profiles.
[HY-BOARD-1140]
🌟 Dynamic Clinical Key:
Octreotide is a synthetic somatostatin analog with a long half-life. It is used clinically to treat acromegaly, carcinoid syndrome, and VIPomas, and is also used to control acute variceal bleeding by reducing splanchnic blood flow and portal pressure. Recognize that blocking some compensatory mechanisms (like reducing hyperventilation in respiratory compensation) can hasten acidotic collapse. Always adjust therapeutic doses based on age-related glomerular filtration clearance.